Funder
Medical Research Council grant
MRC Genomics-Transcriptomics Core
Subject
Cell Biology,Molecular Biology
Reference35 articles.
1. Emerging combinatorial hormone therapies for the treatment of obesity and T2DM;Sadry;Nature Reviews Endocrinology,2013
2. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study;Ambery;Lancet,2018
3. A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials;Tillner;Diabetes, Obesity and Metabolism,2019
4. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial;Frias,2018
5. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation;Hayes;Cell Metabolism,2011
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献